Below are the top small-cap drug manufacturers stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year.
Lannett Company (NYSE:
LCI) is likely to earn $2.08 per share in the next year ending June, 2015. Lannett's trailing-twelve-month operating margin is 13.06%.
POZEN (NASDAQ:
POZN) may earn $1.28 per share in the next year ending December, 2015. POZEN's PEG ratio is 0.43.
DepoMed (NASDAQ:
DEPO) is projected to earn $0.51 per share for the next year ending December, 2015. DepoMed's trailing-twelve-month revenue is $120.19 million.
SciClone Pharmaceuticals (NASDAQ:
SCLN) is expected to earn $0.45 per share over the next year ending December, 2015. SciClone Pharma's trailing-twelve-month ROE is 8.71%.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
